Wanted pages
Jump to navigation
Jump to search
List of non-existing pages with the most links to them, excluding pages which only have redirects linking to them. For a list of non-existent pages that have redirects linking to them, see the list of broken redirects.
Showing below up to 50 results in range #551 to #600.
- Panobacumab (2 links)
- Paroxysmal nocturnal hemoglobinuria (2 links)
- Parsatuzumab (2 links)
- Pascolizumab (2 links)
- Pasotuxizumab (2 links)
- Pateclizumab (2 links)
- Patritumab (2 links)
- Pembrolizumab (2 links)
- Pemtumomab (2 links)
- Perakizumab (2 links)
- Percutaneous coronary intervention (2 links)
- Pertuzumab (2 links)
- Pexelizumab (2 links)
- Phosphatidylserine (2 links)
- Pidilizumab (2 links)
- Pinatuzumab vedotin (2 links)
- Pintumomab (2 links)
- Placulumab (2 links)
- Platelet-derived growth factor receptor alpha (2 links)
- Platelet aggregation inhibitor (2 links)
- Plozalizumab (2 links)
- Pogalizumab (2 links)
- Polatuzumab vedotin (2 links)
- Polymyositis (2 links)
- Ponezumab (2 links)
- Prezalizumab (2 links)
- Priliximab (2 links)
- Pritoxaximab (2 links)
- Pritumumab (2 links)
- Programmed cell death 1 (2 links)
- Prostate cancer (2 links)
- Pseudomonas aeruginosa (2 links)
- Psoriasis (2 links)
- Psoriasis arthritis (2 links)
- Psoriatic Arthritis (2 links)
- Quilizumab (2 links)
- RANKL (2 links)
- RHD (gene) (2 links)
- RTN4 (2 links)
- Rabies (2 links)
- Racotumomab (2 links)
- Radretumab (2 links)
- Rafivirumab (2 links)
- Ralpancizumab (2 links)
- Ramucirumab (2 links)
- Ranibizumab (2 links)
- Raxibacumab (2 links)
- Real-time PCR (2 links)
- Refanezumab (2 links)
- Regavirumab (2 links)